Hearing response following internal auditory ...
Type de document :
Article dans une revue scientifique: Article original
DOI :
PMID :
URL permanente :
Titre :
Hearing response following internal auditory canal decompression in neurofibromatosis type 2
Auteur(s) :
Bonne, Nicolas-Xavier [Auteur]
Risoud, Michael [Auteur]
Hoa, Michael [Auteur]
Lemesre, Pierre-Emmanuel [Auteur]
Médicaments et biomatériaux à libération contrôlée: mécanismes et optimisation - Advanced Drug Delivery Systems - U 1008 [MBLC - ADDS]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Aboukais, Rabih [Auteur]
Le Rhun, Emilie [Auteur]
Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
Dubrulle, Frederique [Auteur]
Baroncini, Marc [Auteur]
Lejeune, Jean-Paul [Auteur]
Thérapies Laser Assistées par l'Image pour l'Oncologie - U 1189 [ONCO-THAI]
Thérapies Lasers Assistées par l'Image pour l'Oncologie (ONCO-THAI) - U1189
Vincent, Christophe [Auteur]
Advanced Drug Delivery Systems (ADDS) - U1008
Médicaments et biomatériaux à libération contrôlée: mécanismes et optimisation - Advanced Drug Delivery Systems - U 1008 [MBLC - ADDS]
Risoud, Michael [Auteur]
Hoa, Michael [Auteur]
Lemesre, Pierre-Emmanuel [Auteur]
Médicaments et biomatériaux à libération contrôlée: mécanismes et optimisation - Advanced Drug Delivery Systems - U 1008 [MBLC - ADDS]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Aboukais, Rabih [Auteur]
Le Rhun, Emilie [Auteur]
Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM) - U1192
Dubrulle, Frederique [Auteur]
Baroncini, Marc [Auteur]
Lejeune, Jean-Paul [Auteur]
Thérapies Laser Assistées par l'Image pour l'Oncologie - U 1189 [ONCO-THAI]
Thérapies Lasers Assistées par l'Image pour l'Oncologie (ONCO-THAI) - U1189
Vincent, Christophe [Auteur]
Advanced Drug Delivery Systems (ADDS) - U1008
Médicaments et biomatériaux à libération contrôlée: mécanismes et optimisation - Advanced Drug Delivery Systems - U 1008 [MBLC - ADDS]
Titre de la revue :
Neurosurgery
Nom court de la revue :
Neurosurgery
Date de publication :
2019-03-19
ISSN :
1524-4040
Mot(s)-clé(s) :
Vestibular schwannoma
Middle fossa craniotomy
Hearing
Deafness
Acoustic neuroma
Neurofibromatosis type 2
Middle fossa craniotomy
Hearing
Deafness
Acoustic neuroma
Neurofibromatosis type 2
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Hearing response following an osteodural decompression of the internal auditory canal (IAC) is controversial.
To evaluate the course of auditory brainstem responses (ABRs) and the early hearing response during the first ...
Lire la suite >Hearing response following an osteodural decompression of the internal auditory canal (IAC) is controversial. To evaluate the course of auditory brainstem responses (ABRs) and the early hearing response during the first year following IAC decompression for small to medium-sized vestibular schwannomas occurring in neurofibromatosis type 2 (NF2). Retrospective chart review of middle fossa craniotomy for IAC osteodural decompression in NF2-related vestibular schwannomas. Twelve NF2 patients were operated on from 2011 to 2016 for IAC decompression. All had NF2 according to the Manchester criteria. All had a progressive change of their ABRs documented from the diagnosis of NF2 over a mean period of 6.25 [0.36;10.9] yr. Treatment was proposed to stop hearing progression based on the speech discrimination scores (SDSs; n = 4) or for hearing maintenance (n = 8). In patients with prior hearing progression, hearing responses were observed in 3 of the 4 patients during the first year. One patient kept on progressing. In the hearing maintenance group, the SDSs remained stable. SDSs improved from 85% [20-100] to 92.5% [60-100] on average (n = 12) and from 55% [20-80] to 77.5% [50-100] in the hearing progression group (n = 4). ABRs improved in 4 patients following decompression. IAC decompression allows early objective hearing responses in select patients. We suggest that the procedure should be offered to patients with hearing progression based on their SDSs and/or associated progressive increases in their wave III and V latencies on ABRs.Lire moins >
Lire la suite >Hearing response following an osteodural decompression of the internal auditory canal (IAC) is controversial. To evaluate the course of auditory brainstem responses (ABRs) and the early hearing response during the first year following IAC decompression for small to medium-sized vestibular schwannomas occurring in neurofibromatosis type 2 (NF2). Retrospective chart review of middle fossa craniotomy for IAC osteodural decompression in NF2-related vestibular schwannomas. Twelve NF2 patients were operated on from 2011 to 2016 for IAC decompression. All had NF2 according to the Manchester criteria. All had a progressive change of their ABRs documented from the diagnosis of NF2 over a mean period of 6.25 [0.36;10.9] yr. Treatment was proposed to stop hearing progression based on the speech discrimination scores (SDSs; n = 4) or for hearing maintenance (n = 8). In patients with prior hearing progression, hearing responses were observed in 3 of the 4 patients during the first year. One patient kept on progressing. In the hearing maintenance group, the SDSs remained stable. SDSs improved from 85% [20-100] to 92.5% [60-100] on average (n = 12) and from 55% [20-80] to 77.5% [50-100] in the hearing progression group (n = 4). ABRs improved in 4 patients following decompression. IAC decompression allows early objective hearing responses in select patients. We suggest that the procedure should be offered to patients with hearing progression based on their SDSs and/or associated progressive increases in their wave III and V latencies on ABRs.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
CHU Lille
Inserm
Université de Lille
Inserm
Université de Lille
Collections :
Date de dépôt :
2021-01-20T15:59:17Z
2023-04-21T10:44:11Z
2024-01-22T08:49:49Z
2023-04-21T10:44:11Z
2024-01-22T08:49:49Z